iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.
about
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.Tumor penetrating peptides for improved drug delivery.Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus.iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.Biodistribution and evaluation of 131 I-labeled neuropilin-binding peptide for targeted tumor imaging.Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin.Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus.Peptides as drug delivery vehicles across biological barriers
P2860
Q35868066-3977D856-878B-4864-BAD3-F6B77A38F986Q35978545-076D0610-1958-4E2B-9478-C80D49EEE5F6Q38831184-6BE15409-6C80-4577-9DDD-9E7A6A6939A2Q40092902-8D07756D-7379-401B-B1B6-BA17069DAEC7Q46505275-32BADD93-F975-4A9F-83F1-2835A84F4A46Q51470465-E11E13A9-8B30-4E07-888E-B9A6F0D83271Q52653896-7BDE344C-23D3-4CDB-85DD-AF967E1F5C2AQ53091050-F50DF1D4-1911-44AA-AE2E-D86C989DBE70Q54959132-9CFDA70D-1925-4A00-BE12-862134B62059Q56889662-544E9208-BF99-4F3A-B33F-9ACE50088005
P2860
iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
iRGD tumor-penetrating peptide ...... nation and antitumor efficacy.
@en
type
label
iRGD tumor-penetrating peptide ...... nation and antitumor efficacy.
@en
prefLabel
iRGD tumor-penetrating peptide ...... nation and antitumor efficacy.
@en
P2093
P2860
P356
P1433
P1476
iRGD tumor-penetrating peptide ...... nation and antitumor efficacy.
@en
P2093
A Figueras
C Puig-Saus
P2860
P2888
P304
P356
10.1038/GT.2014.52
P577
2014-06-19T00:00:00Z